Clinical trial
Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin…
NCT00080275 · Kos Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00080275 |
|---|---|
| Title | Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS) |
| Official title | An Open-Label Evaluation of the Safety and Efficacy of a Combination of Niacin ER and Simvastatin in Patients With Dyslipidemia (OCEANS) |
| Lead sponsor | Kos Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Niacin Extended-Release and simvastatin Tablets |
| Enrollment | 600 |
| Start date | Mar 1, 2004 |
| First posted | Mar 29, 2004 |
| Last update posted | Nov 1, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: